Current rabies vaccines and prophylaxis schedules: Preventing rabies before and after exposure

Travel Medicine and Infectious Disease

Volumn 10, Issue 1, 2012, Pages 1-15

  Warrell, M J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

4 Site; Intradermal; Post exposure; Pre exposure; Travel

Indexed keywords

ALCOHOL; AMODIAQUINE; ANTIBIOTIC AGENT; CHLOROQUINE; DIPLOID CELL VACCINE; MEASLES VACCINE; POVIDONE IODINE; PROCAINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VAXIRAB;

ANAPHYLAXIS; ANTIBODY TITER; ARTICLE; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENCY; ECONOMIC ASPECT; EXPOSURE; FEVER; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE IRRITATION; INJECTION SITE PAIN; MALAISE; MALARIA; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PHASE 1 CLINICAL TRIAL (TOPIC); POST EXPOSURE PROPHYLAXIS; PRE EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROPHYLAXIS; RABIES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; RISK ASSESSMENT; SEROLOGY; TRAVEL; TREATMENT RESPONSE; VACCINATION; WORLD HEALTH ORGANIZATION; WOUND CARE;

ANIMALS; ANTIBODIES, VIRAL; BITES AND STINGS; DOG DISEASES; DOGS; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNIZATION SCHEDULE; INJECTIONS, INTRADERMAL; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RABIES VIRUS; TRAVEL; WORLD HEALTH ORGANIZATION;

EID: 84858768996     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2011.12.005     Document Type: Article

References (149)

1. F. Bahri, A. Letaief, M. Ernez, J. Elouni, T. Chekir, and S. Ben Ammou Neurological complications in adults following rabies vaccine prepared from animal brains Presse Med 25 10 1996 491 493 (Pubitemid 26111430)
2. L.H. Nel Vaccines for lyssaviruses other than rabies Expert Rev Vaccines 4 4 2005 533 540 (Pubitemid 41297300)
3. J.W. Cornwall Statistics of antirabic inoculations in India Brit Med J 298 1923
4. Veeraraghavan N. Pasteur Institute of Southern India Coonoor. Scientific Report 1968 1 Rabies; 1969, 35-80.
5. C. Sitthi-Amorn, V. Jiratanavattana, J. Keoyoo, and N. Sonpunya The diagnostic properties of laboratory tests for rabies Int J Epidem 16 1987 602 605 (Pubitemid 18033137)
6. G.M. Baer Animal models in the pathogenesis and treatment of rabies Rev Infect Dis 10 Suppl. 4 1988 S739 S750
7. K.W. Bernard, D.B. Fishbein, K.D. Miller, R.A. Parker, S. Waterman, and J.W. Sumner Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries Am J Trop Med Hyg 34 1985 633 647 (Pubitemid 15041390)
8. P. Shantavasinkul, T. Tantawichien, S. Wacharapluesadee, A. Jeamanukoolkit, P. Udomchaisakul, and P. Chattranukulchai Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations Clin Infect Dis 50 1 2010 Jan 1 77 79
9. E.K. Kuwert, C. Barsenbach, J. Werner, I. Marcus, N. Scheirmann, and Grosse-Wilde Early/high and late/low responders among HDCS vaccines? E.K. Kuwert, T.J. Wiktor, H. Koprowski, Cell culture rabies vaccines and their protective effect in man 1981 International Green Cross Geneva 160 167
10. C. Strady, R. Jaussaud, I. Beguinot, M. Lienard, and A. Strady Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy Vaccine 18 24 2000 2661 2667 (Pubitemid 30211573)
11. M.C. Schneider, X.P. Aguilera, J. Barbosa da Silva Junior, S.K. Ault, P. Najera, and J. Martinez Elimination of neglected diseases in Latin America and the Caribbean: a mapping of selected diseases PLoS Negl Trop Dis 5 2 2011 e964
12. F.X. Meslin Rabies as a traveler's risk, especially in high-endemicity areas J Travel Med 12 Suppl. 1 2005 S30 S40
13. J. Lang, D.Q. Hoa, N.V. Gioi, N.C. Vien, C.V. Nguyen, and N. Rouyrre Immunogenicity and safety of low-dose intradermal rabies vaccination given during an expanded programme on immunization session in Viet Nam: results of a comparative randomized trial Trans R Soc Trop Med Hyg 93 2 1999 208 213 (Pubitemid 29233864)
14. T. Kamoltham, W. Thinyounyong, P. Phongchamnaphai, P. Phraisuwan, P. Khawplod, and A. Banzhoff Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe J Pediatr 151 2 2007 173 177 (Pubitemid 47079048)
15. N.C. Vien, E. Feroldi, and J. Lang Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children Trans R Soc Trop Med Hyg 102 2008 294 296
16. WHO WHO expert committee on rabies. Seventh report. Technical report series 709 1984 World Health Organization Geneva
17. R.H. Behrens, and R. Steffen Travel health G.C. Cook, A.I. Zumla, Manson's tropical diseases 22nd ed. 2009 Saunders, Elsevier 515 525
18. P. Pandey, D.R. Shlim, W. Cave, and M.F. Springer Risk of possible exposure to rabies among tourists and foreign residents in Nepal J Travel Med 9 3 2002 127 131 (Pubitemid 34654305)
19. P.M. Arguin, J.W. Krebs, E. Mandel, T. Guzi, and J.E. Childs Survey of rabies preexposure and postexposure prophylaxis among missionary personnel stationed outside the United States J Travel Med 7 1 2000 10 14 (Pubitemid 30126843)
20. C.F. Hatz, J.M. Bidaux, K. Eichenberger, U. Mikulics, and T. Junghanss Circumstances and management of 72 animal bites among long-term residents in the tropics Vaccine 13 1995 811 815
21. M. Menachem, M. Grupper, A. Paz, and I. Potasman Assessment of rabies exposure risk among Israeli travelers Travel Med Infect Dis 6 1-2 2008 12 16 (Pubitemid 351372737)
22. K.W. Bernard, and D.B. Fishbein Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost? Vaccine 9 1991 833 836
23. W. Piyaphanee, P. Shantavasinkul, W. Phumratanaprapin, P. Udomchaisakul, P. Wichianprasat, and M. Benjavongkulchai Rabies exposure risk among foreign backpackers in southeast Asia Am J Trop Med Hyg 82 2010 1168 1171
24. V. Field, P. Gautret, P. Schlagenhauf, G.D. Burchard, E. Caumes, and M. Jensenius Travel and migration associated infectious diseases morbidity in Europe, 2008 BMC Infect Dis 10 2010 330
25. P. Phanuphak, S. Ubolyam, and S. Sirivichayakul Should travellers in rabies endemic areas receive pre-exposure rabies immunization? Ann Med Interne (Paris) 145 1994 409 411 (Pubitemid 24372305)
26. P. Gautret, E. Schwartz, M. Shaw, G. Soula, P. Gazin, and J. Delmont Animal-associated injuries and related diseases among returned travellers: a review of the geosentinel surveillance network Vaccine 25 2007 2656 2663 (Pubitemid 46400926)
27. P. LeGuerrier, P.A. Pilon, D. Deshaies, and R. Allard Pre-exposure rabies prophylaxis for the international traveller: a decision analysis Vaccine 14 1996 167 176 (Pubitemid 26072864)
28. L. Wijaya, L. Ford, and D. Lalloo Rabies postexposure prophylaxis in a UK travel clinic: ten years' experience J Travel Med 18 2011 257 261
29. M. Roumiantzeff, N. Ajjan, and J.C. Vincent-Falquet Experience with preexposure rabies vaccination Rev Infect Dis 10 Suppl. 4 1988 S751 S757
30. A. Strady, J. Lang, M. Lienard, C. Blondeau, R. Jaussaud, and S.A. Plotkin Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy J Infect Dis 177 1998 1290 1295 (Pubitemid 28194268)
31. K. Pengsaa, K. Limkittikul, A. Sabchareon, C. Ariyasriwatana, P. Chanthavanich, and P. Attanath A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine Pediatr Infect Dis J 28 2009 335 337
32. WHO WHO Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies WHO/EMC/ZOO.96.6 1997 http://whqlibdoc.who.int/hq/1996/WHO-EMC-ZOO-96.6.pdf [accessed 13.09.1911]
33. WHO rabies vaccines: WHO position paper Wkly Epidemiol Rec 82 2007 425 435 http://www.who.int/wer/2007/wer8249-50.pdf [accessed 13.09.1911]
34. Human rabies prevention-United States, 2008. Recommendations of the advisory committee on immunization practices (ACIP) MMWR Recomm Rep 57 RR-3 2008 1 28
35. D.B. Fishbein, R.E. Pacer, D.F. Holmes, A.B. Ley, P. Yager, and T.C. Tong Rabies preexposure prophylaxis with human diploid cell rabies vaccine: a dose-response study J Infect Dis 156 1987 50 55 (Pubitemid 17095028)
36. M.B. Teunissen, M. Haniffa, and M.P. Collin Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design Curr Top Microbiol Immunol 351 2012 25 76
37. G.S. Turner, F.Y. Aoki, K.G. Nicholson, D.A. Tyrrell, and L.E. Hill Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small doses Lancet 1 1976 1379 1381
38. Immunisation against infectious disease 1984 H.M.S.O. London
39. D. Brown, J.J. Featherstone, A.R. Fooks, S. Gettner, E. Lloyd, and M. Schweiger Intradermal pre-exposure rabies vaccine elicits long lasting immunity Vaccine 26 2008 3909 3912
40. W. Jaijaroensup, S. Limusanno, P. Khawplod, K. Serikul, P. Chomchay, and W. Kaewchomphoo Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination J Travel Med 6 1999 234 237
41. J.H. Cox, and L.G. Schneider Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine J Clin Microbiol 3 1976 96 101
42. D.J. Mills, C.L. Lau, E.J. Fearnley, and P. Weinstein The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule-a case series of 420 travelers J Travel Med 18 2011 327 332
43. M. Altmann, P. Parola, J. Delmont, P. Brouqui, and P. Gautret Knowledge, attitudes, and practices of French travelers from Marseille regarding rabies risk and prevention J Travel Med 16 2009 107 111
44. An advisory committee statement (ACS), National advisory committee on immunization (NACI) Canada communicable disease report 31, ACS-5 1 June 2005 http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/asc-dcc-5/index-eng.php [accessed 13.09.1911]
45. Australian bat lyssavirus infection and rabies 3.1 9th ed. Australian immunisation handbook 2008 http://www.immunise.health.gov.au/internet/immunise/ publishing.nsf/Content/Handbook-lyssavirus [accessed 13.09.1911]
46. Rabies prevention: supplementary statement on the preexposure use of human diploid cell rabies vaccine by the intradermal route MMWR Morb Mortal Wkly Rep 35 1986 767 768
47. J.K. Hickling, K.R. Jones, M. Friede, D. Zehrung, D. Chen, and D. Kristensen Intradermal delivery of vaccines: potential benefits and current challenges Bull World Health Organ 89 2011 221 226
48. M. Pappaioanou, D.B. Fishbein, D.W. Dreesen, I.K. Schwartz, G.H. Campbell, and J.W. Sumner Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine N Engl J Med 314 1986 280 284 (Pubitemid 16146601)
49. S.C. Lau Intradermal rabies vaccination and concurrent use of mefloquine J Travel Med 6 1999 140 141 (Pubitemid 29252125)
50. P.R. Schnurrenberger, W.J. Bashe, and J.H. Helwig Avian embryo rabies immunization. 3. Optimal site and timing of intradermal inoculations in pre-exposure regimens Am J Epidemiol 81 1965 146 149
51. F.B. Peck Jr., and K.C. Kohlstaedt Pre-exposure rabies prophylaxis problems and Procedures Ind Med Surg 33 1964 17 21
52. World Health Organisation Rabies vaccines: WHO position paper Wkly Epidemiol Rec 85 2010 309 320
53. E.V. Knoop, C.M. Freuling, J. Kliemt, T. Selhorst, F.J. Conraths, and T. Muller Evaluation of a commercial rabies ELISA as a replacement for serum neutralization assays as part of the pet travel scheme and oral vaccination campaigns of foxes Berl Munch Tierarztl Wochenschr 123 2010 278 285
54. S.M. Moore, and C.A. Hanlon Rabies-specific antibodies: measuring surrogates of protection against a fatal disease PLoS Negl Trop Dis 4 2010 e595
55. M. Feyssaguet, L. Dacheux, L. Audry, A. Compoint, J.L. Morize, and I. Blanchard Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people Vaccine 25 2007 2244 2251 (Pubitemid 46237682)
56. Working Group II, WHO Expert Committee Vaccine potency requirements for reduced immunization schedules and pre-exposure treatment Develop Biol Stand 40 1978 268 270
57. Rabies prevention-United States, 1984 MMWR Morb Mortal Wkly Rep 33 1984 393 402 7-8
58. C. Lau, and J. Sisson The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic J Travel Med 9 2002 285 288 (Pubitemid 35447328)
59. M.M. Shaw, P.A. Leggat, and M.L. Williams Intradermal pre-exposure rabies immunisation in New Zealand Travel Med Infect Dis 4 2006 29 33 (Pubitemid 43193275)
60. A. Gherardin, and S. Lau Intradermal rabies vaccine Med J Aust 187 2007 58 59
61. C.V. Trimarchi, and M. Safford Jr. Poor response to rabies vaccination by the intradermal route JAMA 268 1992 874
62. U. Thisyakorn, C. Pancharoen, K. Ruxrungtham, S. Ubolyam, P. Khawplod, and T. Tantawichien Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1 Clin Infect Dis 30 2000 218 (Pubitemid 30067094)
63. U. Thisyakorn, C. Pancharoen, and H. Wilde Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination Vaccine 19 2001 1534 1537 (Pubitemid 32332741)
64. T. Tantawichien, W. Jaijaroensup, P. Khawplod, and V. Sitprija Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts Clin Infect Dis 33 2001 E122 E124
65. W. Jaijaroensup, T. Tantawichien, P. Khawplod, S. Tepsumethanon, and H. Wilde Postexposure rabies vaccination in patients infected with human immunodeficiency virus Clin Infect Dis 28 1999 913 914 (Pubitemid 29169440)
66. L.B. Gelinck, C.M. Jol-van der Zijde, A.M. Jansen-Hoogendijk, D.M. Brinkman, J.T. van Dissel, and M.J. van Tol Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART Aids 23 2009 2451 2458
67. A.M. Geretti, G. Brook, C. Cameron, D. Chadwick, R.S. Heyderman, and E. MacMahon British HIV association guidelines for immunization of HIV-infected adults 2008 HIV Med 9 2008 795 848
68. T. Maier, A. Schwarting, D. Mauer, R.S. Ross, A. Martens, and V. Kliem Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus Clin Infect Dis 50 2010 1112 1119
69. A. Srinivasan, E.C. Burton, M.J. Kuehnert, C. Rupprecht, W.L. Sutker, and T.G. Ksiazek Transmission of rabies virus from an organ donor to four transplant recipients N Engl J Med 352 2005 1103 1111 (Pubitemid 40365351)
70. A. Fayaz, S. Simani, A. Janani, F. Farahtaj, P. Biglari, and N. Howeizi Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV) Vaccine 29 2011 3742 3745
71. D.B. Fishbein, K.W. Bernard, K.D. Miller, T. Van der Vlugt, C.E. Gains, and J.T. Bell The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine Am J Trop Med Hyg 35 1986 663 670 (Pubitemid 16089992)
72. WHO world health organization expert consultation on rabies. First report. WHO technical report series 931 2005 http://www.wpro.who.int/NR/ rdonlyres/B1ED8443-0993-408C-BF09-D1D06A6E1B45/0/ FINALTEXTWHOTechnicalReportSeries090605.pdf [accessed 13.09.1911]
73. M.G. Täuber, R. Putzi, P. Fuchs, R. Wyler, and R. Luthy High rate of insufficient antibody titers after single-day immunization with human diploid-cell-strain vaccine against rabies Klin Wochenschr 64 1986 518 521 (Pubitemid 16055767)
74. M.M. Kaplan, and D. Cohen Studies on the local treatment of wounds for the prevention of rabies Bull World Health Organ 1962 765 775
75. H. Bourhy, M. Goudal, A. Mailles, M. Sadkowska-Todys, L. Dacheux, and H. Zeller Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe? Euro Surveill 14 2009
76. E.K. Kuwert, I. Marcus, and P.G. Hoher Neutralizing and complement-fixing antibody responses in pre- and post-exposure vaccines to a rabies vaccine produced in human diploid cells J Biol Stand 4 1976 249 262
77. S.A. Plotkin, T.J. Wiktor, H. Koprowski, E.I. Rosanoff, and H. Tint Immunization schedules for the new human diploid cell vaccine against rabies Am J Epidemiol 103 1976 75 80
78. S.A. Plotkin, and T. Wiktor Rabies vaccination Annu Rev Med 29 1978 583 591
79. WHO WHO expert committee on rabies. Eighth report. Technical report series 824 1992 World Health Organization Geneva
80. I. Vodopija, P. Sureau, M. Lafon, Z. Baklaic, M. Ljubicic, and M. Svjetlicic An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule Vaccine 4 1986 245 248 (Pubitemid 17231921)
81. I. Vodopija, P. Sureau, S. Smerdel, M. Lafon, Z. Baklaic, and M. Ljubicic Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment Vaccine 6 1988 283 286
82. S. Chutivongse, H. Wilde, D.B. Fishbein, G.M. Baer, and T. Hemachudha One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and vero cell rabies vaccine Vaccine 9 1991 573 576
83. C. Wasi, P. Chaiprasithikul, P. Auewarakul, P. Puthavathana, P. Thongcharoen, and M. Trishnananda The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment Southeast Asian J Trop Med Public Health 24 1993 461 466 (Pubitemid 24055550)
84. J. Lang, G.H. Simanjuntak, S. Soerjosembodo, and C. Koesharyono Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 clinical investigator group Bull World Health Organ 76 1998 491 495 (Pubitemid 29014264)
85. C.E. Rupprecht, D. Briggs, C.M. Brown, R. Franka, S.L. Katz, and H.D. Kerr Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals Vaccine 27 2009 7141 7148
86. C.E. Rupprecht, D. Briggs, C.M. Brown, R. Franka, S.L. Katz, and H.D. Kerr Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices MMWR Recomm Rep 59 2010 1 9
87. Uwanyiligira M, Landry P, Genton B de Vallire S. Do travelers receive timely and adequate rabies post-exposure prophylaxis? In: 12th conference of the international society of travel medicine in Boston, May 8-12, 2011.
88. M.J. Warrell, D.A. Warrell, P. Suntharasamai, C. Viravan, A. Sinhaseni, and D. Udomsakdi An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis Lancet 2 1983 301 304 (Pubitemid 13075900)
89. M.J. Warrell, P. Suntharasamai, K.G. Nicholson, D.A. Warrell, P. Chanthavanich, and C. Viravan Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens Lancet 1 1984 874 876 (Pubitemid 14132389)
90. M.J. Warrell, K.G. Nicholson, D.A. Warrell, P. Suntharasamai, P. Chanthavanich, and C. Viravan Economical multiple-site intradermal immunisation with human diploid- cell-strain vaccine is effective for post-exposure rabies prophylaxis Lancet i 1985 1059 1062 (Pubitemid 15075504)
91. P. Suntharasamai, M.J. Warrell, C. Viravan, P. Chanthavanich, S. Looareesuwan, and A. Supapochana Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis Epidemiol Infect 99 1987 755 765 (Pubitemid 18034349)
92. S.N. Madhusudana, N.P. Anand, and R. Shamsundar Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies Natl Med J India 14 2001 145 147 (Pubitemid 32634728)
93. S.N. Madhusudana, N.P. Anand, and R. Shamsundar Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals Int J Infect Dis 6 2002 210 214
94. WHO Report of informal discussions on intra-dermal application of modern rabies vaccines for human post-exposure treatment 22 January 1993 Geneva, WHO/Rab.Res./93.41. 1993
95. P. Phanuphak, P. Khawplod, S. Sirivichayakul, W. Siriprasomsub, S. Ubol, and M. Thaweepathomwat Humoral and cell-mediated immune responses to various economical regimens of purified vero cell rabies vaccine Asian Pac J Allergy Immunol 5 1987 33 37
96. S. Chutivongse, H. Wilde, C. Supich, G.M. Baer, and D.B. Fishbein Postexposure prophylaxis for rabies with antiserum and intradermal vaccination Lancet 335 1990 896 898 (Pubitemid 20136790)
97. WHO Expert Committee on rabies. Eighth report. Technical report series 824 1992 World Health Organization Geneva http://whqlibdoc.who.int/trs/WHO-TRS- 840.pdf [accessed 11.09.1911]
98. P. Suntharasamai, P. Chaiprasithikul, C. Wasi, W. Supanaranond, P. Auewarakul, and P. Chanthavanich A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis Vaccine 12 1994 508 512 (Pubitemid 24122856)
99. S.N. Madhusudana, T.V. Sanjay, B.J. Mahendra, and M.S. Suja Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai red cross regimen Int J Infect Dis 8 2004 175 179
100. D.J. Briggs, A. Banzhoff, U. Nicolay, S. Sirikwin, B. Dumavibhat, and S. Tongswas Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine Bull World Health Organ 78 2000 693 698 (Pubitemid 30398852)
101. B.P. Quiambao, E.M. Dimaano, C. Ambas, R. Davis, A. Banzhoff, and C. Malerczyk Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai red cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals Vaccine 23 2005 1709 1714 (Pubitemid 40215705)
102. S.N. Madhusudana, T.V. Sanjay, B.J. Mahendra, M.K. Sudarshan, D.H. Narayana, and A. Giri Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai red cross intradermal regimen at a dose of 0.1 ml Hum Vaccin 2 2006 200 204 (Pubitemid 44786801)
103. B. Dodet An important date in rabies history Vaccine 25 2007 8647 8650 (Pubitemid 350192053)
104. G. Gongal, and A.E. Wright Human rabies in the WHO southeast Asia region: forward steps for elimination Adv Prev Med 2011 2011 383870
105. K. Hampson, S. Cleaveland, and D. Briggs Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries PLoS Negl Trop Dis 5 2011 e982 http://www.plosntds.org/attachments/pntd.0000982- Response-to-Warrell16Mar11.pdf Comment: Comparison of PEP Vaccination regimens including the proposed 4-site ID regimen reduced to a schedule with 3 clinic visits. [accessed 13.09.1911]
106. A. Goswami, J. Plun-Favreau, N. Nicoloyannis, G. Sampath, M.N. Siddiqui, and J.A. Zinsou The real cost of rabies post-exposure treatments Vaccine 23 2005 2970 2976 (Pubitemid 40462435)
107. M.J. Warrell, A. Riddell, L.M. Yu, J. Phipps, L. Diggle, and H. Bourhy A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods PLoS Negl Trop Dis 2 2008 e224
108. B.P. Quiambao, C. Gepanayao, N. Bermal, M.C. Ambas, H. Dy-Tioco, and M. Christomo Immunogenicity and safety of three intradermal anti-rabies vaccination regimens using purified vero cell rabies vaccine APCRI J 10 2008 15 19
109. A. Ambrozaitis, A. Laiskonis, L. Balciuniene, A. Banzhoff, and C. Malerczyk Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen Vaccine 24 2006 4116 4121
110. P. Shantavasinkul, T. Tantawichien, H. Wilde, A. Sawangvaree, A. Kumchat, and N. Ruksaket Postexposure rabies prophylaxis completed in 1 week: preliminary study Clin Infect Dis 50 2010 56 60
111. B. Dodet Report of the fifth AREB meeting Ho Chi Minh City, Vietnam, 17-20 November 2008 Vaccine 27 2009 2403 2407
112. Commentary. Proposed new rabies control guidelines (highlights from the WHO consultation on human and dog rabies prevention and control, Veryier du lac, France, 7-9 October, 2009 Asian Biomed 3 2009 753 756 http://www.asianbiomed. org/htdocs/previous/A20093751.pdf [accessed 13.09.1911]
113. G.S. Turner, K.G. Nicholson, D.A. Tyrrell, and F.Y. Aoki Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization J Hyg (Lond) 89 1982 101 110 (Pubitemid 12051344)
114. D.J. Briggs, D.W. Dreesen, U. Nicolay, J.E. Chin, R. Davis, and C. Gordon Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons Vaccine 19 2000 1055 1060 (Pubitemid 32010698)
115. C. Kositprapa, K. Limsuwun, H. Wilde, W. Jaijaroensup, A. Saikasem, and P. Khawplod Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations Clin Infect Dis 25 1997 614 616 (Pubitemid 27392601)
116. N. Naraporn, P. Khawplod, K. Limsuwan, P. Thipkong, C. Herzog, and R. Glueck Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously J Travel Med 6 1999 134 136 (Pubitemid 29252123)
117. K. Suwansrinon, H. Wilde, M. Benjavongkulchai, U. Banjongkasaena, S. Lertjarutorn, and S. Boonchang Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity Vaccine 24 2006 3878 3880
118. T. Tantawichien, M. Benjavongkulchai, K. Limsuwan, P. Khawplod, W. Kaewchompoo, and P. Chomchey Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine Clin Infect Dis 28 1999 1100 1103 (Pubitemid 29203546)
119. P. Khawplod, M. Benjavongkulchai, S. Limusanno, S. Chareonwai, W. Kaewchompoo, and T. Tantawichien Four-site intradermal postexposure boosters in previously rabies vaccinated subjects J Travel Med 9 2002 153 155 (Pubitemid 34654310)
120. P. Shantavasinkul, T. Tantawichien, W. Jaijaroensup, S. Lertjarutorn, A. Banjongkasaena, and H. Wilde A 4-site, single-visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: experiences with >5000 patients Clin Infect Dis 51 2010 1070 1072
121. S. Toovey Preventing rabies with the verorab vaccine: 1985-2005 twenty years of clinical experience Travel Med Infect Dis 5 2007 327 348 (Pubitemid 350011953)
122. A. Dobardzic, H. Izurieta, E.J. Woo, J. Iskander, S. Shadomy, and C. Rupprecht Safety review of the purified chick embryo cell rabies vaccine: data from the vaccine adverse event reporting system (VAERS), 1997-2005 Vaccine 25 2007 4244 4251 (Pubitemid 46635939)
123. V.J. Cabasso Passive immunization G.M. Baer, The Natural history of rabies vol. II 1975 Academic Press New York 319 340
124. K. Suwansrinon, W. Jaijareonsup, H. Wilde, M. Benjavongkulchai, C. Sriaroon, and V. Sitprija Sex- and age-related differences in rabies immunoglobulin hypersensitivity Trans R Soc Trop Med Hyg 101 2007 206 208 (Pubitemid 44835340)
125. T. Muller, B. Dietzschold, H. Ertl, A.R. Fooks, C. Freuling, and C. Fehlner-Gardiner Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans PLoS Negl Trop Dis 3 2009 e542
126. S.E. Sloan, C. Hanlon, W. Weldon, M. Niezgoda, J. Blanton, and J. Self Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates Vaccine 25 2007 2800 2810 (Pubitemid 46412574)
127. J. de Kruif, A.B. Bakker, W.E. Marissen, R.A. Kramer, M. Throsby, and C.E. Rupprecht A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis Annu Rev Med 58 2007 359 368 (Pubitemid 46706520)
128. A.B. Bakker, C. Python, C.J. Kissling, P. Pandya, W.E. Marissen, and M.F. Brink First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity Vaccine 26 2008 5922 5927
129. T.G. Smith, X. Wu, R. Franka, and C.E. Rupprecht Design of future rabies biologics and antiviral drugs Adv Virus Res 79 2011 345 363
130. V. Yusibov, S.J. Streatfield, and N. Kushnir Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond Hum Vaccin 7 2011 313 321
131. K. Ko, Y. Tekoah, P.M. Rudd, D.J. Harvey, R.A. Dwek, and S. Spitsin Function and glycosylation of plant-derived antiviral monoclonal antibody Proc Natl Acad Sci U S A 100 2003 8013 8018 (Pubitemid 36760086)
132. A. Hultberg, N.J. Temperton, V. Rosseels, M. Koenders, M. Gonzalez-Pajuelo, and B. Schepens Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules PLoS One 6 2011 e17665
133. ®: new ammunition to battle viruses Antivir Res 2011 Sep 10 [Epub ahead of print]
134. Y.C. Kim, C. Jarrahian, D. Zehrung, S. Mitragotri, and M.R. Prausnitz Delivery systems for intradermal vaccination Curr Top Microbiol Immunol 351 2012 77 112
135. P.E. Laurent, H. Bourhy, M. Fantino, P. Alchas, and J.A. Mikszta Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults Vaccine 28 2010 5850 5856
136. G. Blanchard-Rohner, A.S. Pulickal, C.M. Jol-van der Zijde, M.D. Snape, and A.J. Pollard Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans Blood 114 2009 4998 5002
137. A. Horowitz, R.H. Behrens, L. Okell, A.R. Fooks, and E.M. Riley NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination J Immunol 185 2010 2808 2818
138. Guinet-Morlot F, Pichon S, Sarcey E, Calvosa E, Chevalier M. Development and characterization of the next generation of purified Vero rabies vaccine (PVRV). XXI international meeting on rabies in the Americas, Guadalajara, Mexico; 2010.
139. J.P. McGettigan Experimental rabies vaccines for humans Expert Rev Vaccines 9 2010 1177 1186
140. X. Wu, R. Franka, H. Henderson, and C.E. Rupprecht Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies Vaccine 29 2011 4195 4201
141. J. Cenna, M. Hunter, G.S. Tan, A.B. Papaneri, E.P. Ribka, and M.J. Schnell Replication- deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates J Infect Dis 200 2009 1251 1260
142. D.W. Dreesen, D.B. Fishbein, D.T. Kemp, and J. Brown Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization Vaccine 7 1989 397 400 (Pubitemid 19252621)
143. A.J. Morrison Jr., E.H. Hunt, N.O. Atuk, J.D. Schwartzman, and R.P. Wenzel Rabies pre-exposure prophylaxis using intradermal human diploid cell vaccine: immunologic efficacy and cost-effectiveness in a university medical center and a review of selected literature Am J Med Sci 293 1987 293 297 (Pubitemid 17082395)
144. A. Sabchareon, J. Lang, P. Attanath, C. Sirivichayakul, K. Pengsaa, and V. Le Mener A new vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children Clin Infect Dis 29 1999 141 149 (Pubitemid 29336816)
145. D.W. Dreesen, D.T. Kemp, J. Brown, and W.J. Brown Antibody response to a single intradermal booster dose of rabies human diploid cell vaccine J Am Vet Med Assoc 183 1983 1468 1470 (Pubitemid 14194236)
146. A. Sabchareon, P. Chantavanich, S. Pasuralertsakul, C. Pojjaroen-Anant, V. Prarinyanupharb, and P. Attanath Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified vero cell rabies vaccine Pediatr Infect Dis J 17 1998 1001 1007 (Pubitemid 28549419)
147. J. Morris, N.S. Crowcroft, A.R. Fooks, S.M. Brookes, and N. Andrews Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination Hum Vaccin 3 2007 165 170 (Pubitemid 47598173)
148. D.J. Briggs, and J.R. Schwenke Longevity of rabies antibody titre in
149. J.T. Horman, J.V. Rullan, R.A. Myers, J.O. Bond, E. Israel, and J.M. Joseph Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine J Am Vet Med Assoc 191 1987 185 187 (Pubitemid 17143219)